Calvitian treatments are not clear, quite the opposite. It is a new Finasterid formula, the most commonly used molecule in the treatment of light to moderate light in humans, which reaches pharmacies, as indicated by the daily life of the pharmacist.
The “Finchrezo” is the first Finasterid -based treatment that is applied directly to the skin, at the beginning of the scalp areas. The dose, the recommended use, is one to four daily aerosols.
This non -refundable product is produced by the Bailleul laboratory. As the Specialized Site of Pharma365 points out, this is the first version of this molecule that is not administered orally. The topical application prevents the molecule from circulating too much in the body, an exposure 100 times lower.
Psychiatric and sexual disorders associated with the molecule
In a notice published in 2019 and updated in October 2024, the National Medication Safety Agency (ANSM) alerted patients with health professionals about “the risks of psychiatric disorders and sexual function by processing by finely, as well as the behavior that will be maintained in case of these undesirable effects.”
“Psychiatric symptoms and disorders were observed such as anxiety, mood changes, in particular depressed mood, depression and less frequently suicidal thoughts during and after the use of finasteride,” warns the health agency.
In the case of the appearance of psychiatric disorders, the treatment must be interrupted. The same happens in the case of sexual disorders, such as erectile dysfunction or decreased libido; Although it is possible to “observe a persistence of these sexual disorders after stopping the treatment.”
Source: BFM TV
